PAPER
C2-Amination of 2,4-Dichloropyridines
2435
13C NMR (125 MHz, DMSO-d6): d = 100.0, 103.9, 111.2, 115.3,
119.1, 119.2, 133.2, 143.6, 143.8, 154.1, 157.3.
13C NMR (125 MHz, DMSO-d6): d = 100.6, 111.6, 115.2, 118.6,
125.1, 141.3, 144.0, 145.7, 154.1, 157.1.
MS (ESI): m/z = 253 and 255 [M – H]–.
MS (ESI): m/z = 273 and 275 [M – H]–.
Anal. Calcd for C13H7ClN4 (30 mol% H2O): C, 60.67; H, 2.86; N,
21.72. Found: C, 60.46; H, 2.59; N, 21.49.
Anal. Calcd for C12H7ClN4O2 (5 mol% pentane): C, 52.87; H, 2.75;
N, 20.13. Found: C, 53.26; H, 2.73; N, 20.34.
6-(4-Acetylphenylamino)-4-chloronicotinonitrile (5e)
1H NMR (500 MHz, CDCl3): d = 2.60 (s, 3 H), 6.95 (s, 1 H, H5),
7.10 (br s, 1 H), 7.51 (d, J = 8.6 Hz, 2 H), 8.01 (d, J = 8.6 Hz, 2 H),
8.50 (s, 1 H, H2).
13C NMR (125 MHz, CDCl3): d = 26.5, 102.1, 109.0, 114.9, 120.0,
130.2, 133.2, 142.3, 146.7, 154.0, 157.3, 196.6.
Palladium-Mediated Amination with Pyridine 6; Typical Pro-
cedure
2,4-Dichloropyridine (6; 100 mg, 0.68 mmol), N-acetyl aminoarene
4 (0.68 mmol), Xantphos (23.5 mg, 0.06 mmol), diacetoxypalladi-
um (4.5 mg, 0.02 mmol) and Cs2CO3 (330 mg, 1.01 mmol) were
weighed out and sealed in a microwave vial. Argon-degassed diox-
ane (2 mL) was added and the resulting mixture was stirred at
110 °C overnight. The reaction mixture was allowed to cool to r.t.,
diluted with a 1 M aq LiOH (2 mL) and stirred at r.t. for 30 min. The
reaction mixture was concentrated, diluted with DMF (1.5 mL),
centrifuged, and the filtrate was purified by preparative HPLC/MS.
The fractions were evaporated to dryness and, depending on the sol-
ubility of the final compound, the residue was triturated in either
EtOAc, pentane, Et2O or a 1:1 mixture of pentane and Et2O. The re-
sulting solid was collected by filtration and dried to afford the title
compound as a solid. Yields are summarized in Table 2.
HRMS-ESI: m/z = 272 and 274 [M + H]+ calcd for C14H11ClN3O:
272.05852; found: 272.05865.
4-Chloro-6-(4-methoxy-2-methylphenylamino)nicotinonitrile
(5f)
1H NMR (500 MHz, CDCl3): d = 2.22 (s, 3 H), 3.83 (s, 3 H), 6.32
(s, 1 H, H5), 6.73 (br s, 1 H), 6.81 (dd, J = 2.6, 8.6 Hz, 1 H), 6.86
(d, J = 2.6 Hz, 1 H), 7.16 (d, J = 8.6 Hz, 1 H), 8.35 (s, 1 H, H2).
13C NMR (125 MHz, CDCl3): d = 18.2, 55.5, 99.7, 105.9, 112.6,
115.5, 116.6, 127.9, 128.3, 136.7, 146.7, 154.1, 159.0, 160.6.
MS (ESI) m/z = 274 and 276 [M + H] +.
4-Chloro-6-(1,3-dimethyl-1H-pyrazol-5-ylamino)nicotinoni-
trile (5k)
1H NMR (500 MHz, CDCl3): d = 2.29 (s, 3 H), 3.69 (s, 3 H), 6.01
(s, 1 H), 6.58 (s, 1 H, H5), 6.68 (br s, 1 H), 8.41 (s, 1 H, H2).
Anal. Calcd for C14H12ClN3O (70 mol% H2O): C, 58.72; H, 4.72; N,
14.67. Found: C, 58.54; H, 4.39; N, 14.42.
13C NMR (125 MHz, CDCl3): d = 14.0, 35.0, 101.3, 102.1, 107.0,
4-Chloro-6-(2-methylisoindolin-4-ylamino)nicotinonitrile (5g)
1H NMR (500 MHz, CDCl3): d = 2.62 (s, 3 H), 3.80 (s, 2 H), 3.98
(s, 2 H), 6.60 (s, 1 H, H5), 6.98 (br s, 1 H), 7.14 (d, J = 7.8 Hz, 1 H),
7.16 (d, J = 8.2 Hz, 1 H), 7.29 (dd, J = 7.8, 8.2 Hz, 1 H), 8.38 (s,
1 H, H2).
13C NMR (125 MHz, CDCl3): d = 42.2, 59.1, 61.2, 100.4, 106.7,
115.3, 120.8, 122.7, 128.5, 131.6, 136.0, 143.3, 146.7, 154.2, 159.0.
114.8, 135.6, 147.5, 148.2, 154.0, 159.3.
MS (ESI): m/z = 248 and 250 [M + H]+.
Anal. Calcd for C11H10ClN5: C, 53.34; H, 4.07; N, 28.27. Found: C,
53.05; H, 3.94; N, 28.15.
4-Chloro-6-(6-methylpyridin-2-ylamino)nicotinonitrile (5l)
1H NMR (500 MHz, CDCl3): d = 2.54 (s, 3 H), 6.87 (d, J = 7.3 Hz,
1 H), 7.13 (d, J = 7.6 Hz, 1 H), 7.59 (dd, J = 7.6, 7.3 Hz, 1 H), 7.71
(br s, 1 H), 8.16 (s, 1 H), 8.46 (s, 1 H).
HRMS (ESI): m/z 285 and 287 [M + H]+ calcd for C15H14ClN4:
285.09015; found: 285.09018.
13C NMR (125 MHz, CDCl3): d = 24.0, 102.3, 109.8, 111.3, 115.1,
4-Chloro-6-(3-chlorophenylamino)nicotinonitrile (5h)
1H NMR (500 MHz, DMSO-d6): d = 6.83 (s, 1 H), 7.06 (s, 1 H),
7.19 (d, J = 6.9 Hz, 1 H), 7.24 (d, J = 7.6 Hz, 1 H), 7.34 (dd,
J = 7.6, 6.9 Hz, 1 H), 7.45 (s, 1 H), 8.43 (s, 1 H).
13C NMR (125 MHz, DMSO-d6): d = 101.5, 108.1, 115.3, 120.3,
122.4, 125.7, 130.8, 135.5, 139.1, 146.8, 154.2, 158.3.
117.8, 138.8, 146.6, 151.4, 151.5, 153.1, 156.3.
HRMS (ESI): m/z 245 and 247 [M + H]+ calcd for C12H10ClN4:
245.05885; found: 245.05893.
4-Chloro-N-(1,3-dimethyl-1H-pyrazol-4-yl)pyridin-2-amine
(5q)
MS (ESI): m/z = 262 and 264 [M – H]–.
1H NMR (500 MHz, CDCl3): d = 2.15 (s, 3 H), 3.85 (s, 3 H), 6.11
(br s, 1 H), 6.38 (s, 1 H), 6.65 (d, J = 4.6 Hz, 1 H), 6.41 (s, 1 H),
8.01 (br s, 1 H).
Anal. Calcd for C12H7Cl2N3 (10 mol% pentane): C, 55.33; H, 3.05;
N, 15.49. Found: C, 55.57; H, 2.73; N, 15.18.
13C NMR (125 MHz, CDCl3): d = 11.0, 39.24, 106.3, 114.5, 119.1,
6-(4-Bromophenylamino)-4-chloronicotinonitrile (5i)
1H NMR (500 MHz, DMSO-d6): d = 7.00 (s, 1 H, H5), 7.52 (d,
J = 8.9 Hz, 2 H), 7.63 (d, J = 8.9 Hz, 2 H), 8.66 (s, 1 H, H2), 10.07
(br s, 1 H).
13C NMR (125 MHz, DMSO-d6): d = 98.7, 110.1, 114.5, 115.6,
121.7, 131.5, 138.5, 143.3, 154.2, 157.7.
127.2, 144.8, 145.4, 149.1, 159.3.
MS (ESI): m/z = 223 and 225 [M + H]+.
Anal. Calcd for C10H11ClN4 (10 mol% EtOAc): C, 53.96; H, 5.14;
N, 24.20. Found: C, 54.14; H, 4.95; N, 24.28.
4-Chloro-6-(6-methylpyridin-2-ylamino)nicotinonitrile (5r)
1H NMR (500 MHz, CDCl3): d = 6.66 (br s, 1 H), 6.78 (dd, J = 1.8,
5.4 Hz, 1 H), 6.82 (d, J = 1.6 Hz, 1 H), 7.05 (d, J = 7.8 Hz, 1 H),
7.20 (d, J = 8.0 Hz, 1 H), 7.26 (d, J = 7.8, 8.0 Hz, 1 H), 7.44 (dd,
J = 1.8, 1.6 Hz, 1 H), 8.11 (d, J = 5.4 Hz, 1 H).
13C NMR (125 MHz, CDCl3): d = 108.9, 116.5, 118.8, 120.7, 123.7,
130.7, 135.4, 141.4, 145.6, 149.7, 156.7.
MS (ESI): m/z = 306, 308 and 310 [M – H]–.
Anal. Calcd for C12H7BrClN3: C, 46.71; H, 2.29; N, 13.62. Found:
C, 46.75; H, 2.08; N, 13.48.
4-Chloro-6-(4-nitrophenylamino)nicotinonitrile (5j)
1H NMR (500 MHz, DMSO-d6): d = 7.16 (s, 1 H, H5), 7.94 (d,
J = 8.9 Hz, 2 H), 8.25 (d, J = 8.9 Hz, 2 H), 8.79 (s, 1 H, H2), 10.60
(br s, 1 H).
MS (ESI): m/z = 239 and 241 [M + H]+.
Synthesis 2011, No. 15, 2431–2436 © Thieme Stuttgart · New York